RxDoctor Payments Data
★ My doctorsLook up a doctor →

Suresh Koneru, MD

Surgery of the Hand · San Antonio, TXNPI 1972503092

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. KCI USA, Inc. accounts for 71.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $10,766 and has fallen 87.5% since, to $1,350 in 2025. Among surgery of the hand clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,766in general payments, 2019–2025

Across 51 payments — averaging $328.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KCI USA, Inc.$12K
  • Musculoskeletal Transplant Foundation Inc.$3K
  • Mentor Worldwide LLC$481
  • TELA Bio, Inc.$344
  • Sientra, Inc.$191
  • Bard Peripheral Vascular, Inc.$189
  • plus $954 from 13 others
$208in research payments, 2019–2025

Across 2 payments — averaging $103.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$208

What the payments were for

  • Consulting fees$8,16449%
  • Speaking & faculty fees$1241%
  • Travel & lodging$5,15831%
  • Food & beverage$3,31920%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
KCI USA, Inc.7$12,042
Musculoskeletal Transplant Foundation Inc.11$2,565
Mentor Worldwide LLC6$481
TELA Bio, Inc.5$344
Sientra, Inc.2$191
Bard Peripheral Vascular, Inc.2$189
Davol Inc.1$178
AbbVie(2 entities)2$159
Organogenesis Inc.3$148
Heron Therapeutics, Inc.1$125
Acelrx Pharmaceuticals, Inc.1$74
Kerecis Limited2$56
Tepha Inc1$52
Galderma Laboratories, L.p.2$46
Pacira Pharmaceuticals Incorporated1$32
Aroa Biosurgery Incorporated1$27
Integra Lifesciences Corporation1$21
Smith+Nephew1$19
Merz North America, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,766 in reported general payments places this provider in the 95th percentile of 68 surgery of the hand providers in Texas.

See all surgery of the hand providers in Texas →

Medicare billing

Part B allowed, 2024
$12,938
Medicare patients
33
Services billed
268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib13$94
Gabapentin12$24

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →